UBS Group AG - KIORA PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

KIORA PHARMACEUTICALS INC's ticker is and the CUSIP is 49721T309. A total of 19 filers reported holding KIORA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
UBS Group AG ownership history of KIORA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$834
+16580.0%
1,468
+18250.0%
0.00%–
Q2 2023$5
-99.1%
8
-95.2%
0.00%–
Q1 2023$555
-96.2%
166
-96.1%
0.00%–
Q4 2022$14,591
+12.2%
4,254
+98.5%
0.00%–
Q3 2022$13,000–2,143–0.00%–
 Download
Other shareholders
KIORA PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
XTX Topco Ltd 11,790$6,9440.00%
ALBION FINANCIAL GROUP /UT 6$40.00%
UBS Group AG 1,468$8340.00%
NewEdge Advisors, LLC 200$1140.00%
OSAIC HOLDINGS, INC. 36$200.00%
FMR LLC 2$10.00%
US BANCORP \DE\ 67$380.00%
WELLS FARGO & COMPANY/MN 113$640.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 37,211$21,9170.00%
View complete list of KIORA PHARMACEUTICALS INC shareholders